Latest News & Upcoming Events
MacuLogix Raises $38.7 Million in Series D Financing Led by Vivo Capital
This funding will be used to further expand the team and company infrastructure to support the growing sales and practice integration efforts of the AdaptDx automated dark adaptometer.
Read Press ReleaseMacuLogix New HQ Announcement
The new headquarters occupies 17,400 square feet of space and was designed as a bright and welcoming environment to accommodate their current and future needs.
Read Press ReleaseMacuLogix Hosts Inaugural AMD Speaker Alliance
MacuLogix proudly hosted the industry’s first AMD Speaker Alliance meeting in January 2019 at the Hotel Hershey which was filled with prestigious and knowledgeable eye care professionals.
Read Press ReleaseMacuLogix Enters International Distribution Agreement with Optos
By expanding the MacuLogix distribution network to include eight new countries, the AdaptDx will reach an additional 260 million people. Partnering with the Optos team will help the company achieve its bold vision of eliminating blindness caused by AMD.
Read Press ReleaseMacuLogix Enters Canadian Distribution Agreement with Clarion Medical Technologies
The AdaptDx is an exciting addition to Clarion’s expansive portfolio of revolutionary ophthalmic devices, lenses, and nutraceuticals.
Read Press ReleaseMacuLogix Launches the AdaptDx in Europe at EURETINA
“Introducing the AdaptDx to the European eyecare community during EURETINA is a major milestone for our company,” said William McPhee, president and CEO of MacuLogix.
Read Press ReleaseMacuLogix Launches AMD Academy
To help you positively impact your patients’ outcomes, we’ve created the AMD Academy™. This is not only a place to view training and learn, but also a growing community. Join the AMD Academy today.
Read Press ReleaseMacuLogix Appoints Director of Professional Relations
Amanda K. Lee, OD joined MacuLogix as Director of Professional Relations. She will serve as a clinical partner to MacuLogix customers, eye care professionals and industry partners.
Read Press ReleaseAdaptDx Used in EU Study
AdaptDx® has been selected as a functional testing device in the MACUSTAR project, a 5-year study to explore AMD.
Read Press ReleaseMacuLogix Featured on Talk Radio Show
“Practical Guidelines for the Treatment of AMD” was the focus of an episode of The Power Hour.
Read Press Release